PARIS: Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and…
PARIS: Nanobiotix announced its global development plan for 2021 and beyond. Nanobiotix is a clinical-stage biotechnology company focused on developing…